Up-regulation of TIMP-3 and RECK decrease the invasion and metastasis ability of colon cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The role of microRNA21 (miR-21) in colon cancer invasion and metastasis is known, but its precise molecular mechanisms remain unclear.
• Understanding the pathways involving miR-21 and its target genes is crucial for developing effective colon cancer therapies.

Purpose of the Study:

• To elucidate the molecular mechanisms of invasion and migration pathways regulated by miR-21 in colon cancer.
• To investigate the in vitro and in vivo effects of miR-21 inhibition on colon cancer cell behavior and target gene expression.

Main Methods:

• Colon cancer cells were transfected with pmiRZip21 to inhibit miR-21 expression.
• miR-21 levels, target gene mRNA and protein expression (TIMP-3, RECK, BMPR-II, PCDH17) were quantified using TaqMan assays, RT-PCR, and Western blot.
• In vitro (scratch migration, Transwell assays) and in vivo (subcutaneous tumor models) experiments assessed invasion and migration.

Main Results:

• Inhibition of miR-21 significantly decreased colon cancer cell invasion and migration both in vitro and in vivo.
• Upregulation of TIMP-3 and RECK mRNA and protein levels was observed after miR-21 inhibition.
• No significant changes in BMPR-II and PCDH17 levels were detected following miR-21 inhibition.

Conclusions:

• Inhibiting miR-21 leads to the upregulation of TIMP-3 and RECK, which in turn reduces colon cancer cell invasion and metastasis.
• Targeting miR-21 presents a promising therapeutic strategy for colon cancer treatment.
• Further in vivo investigations are warranted to fully explore the therapeutic potential of targeting miR-21.